Funding Opportunities

Opportunity Type: Other

Goal: The Advocacy Advancement Award is intended to serve as a mechanism for patient advocacy leaders to answer concrete questions relevant to their own constituents by leveraging shared data, expertise, and resources available through the GLIA-CTN. Award criteria were defined in deliberately broad terms in order to accommodate the diverse and evolving needs of individual leukodystrophy communities.

Sponsor: Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

Eligibility Criteria: Any registered 501(c)(3) nonprofit organization focused on promoting awareness, research, and/or fundraising for leukodystrophy research is eligible to apply for the GLIA-CTN Advocacy Advancement Award.

Application Due Date: Applications accepted on a rolling basis.

Term: Support for six (6) month project

Opportunity Type: Other

Goal: The GLIA-CTN Community Award is intended to encourage continued network growth, diverse membership, and an expanded leukodystrophy workforce by providing investigators external to the GLIA-CTN with in-kind infrastructure support for novel projects. Award recipients will work closely with the GLIA-CTN Biomedical Informatics and Statistical Core (BISC) to refine data collection and management plans, and will benefit from generous access to GLIA-CTN data and/or samples, as well as consultation and support by GLIA-CTN staff with expertise in data management, database design, outcome development and validation, regulatory affairs, etc.

Sponsor: Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

Eligibility Criteria: Candidates for the award must have a doctoral degree within the health professions (e.g., MD, DO, DDS, DMD, OD, DC, PharmD) and be actively affiliated with a US-based academic and/or health care institution. Individuals with degrees in nursing research and/or practice, who are licensed to practice clinically, may be eligible. There are also certain circumstances in which individuals with a PhD may be eligible.

Application Due Date: Applications accepted on a rolling basis.

Term: One Year

Goal: The primary goal of the GLIA-CTN Pilot Project Award is to generate preliminary research data needed to secure more substantial funding through traditional federal, institutional, and/or industry grant mechanisms. Recognizing the importance of creating a sustainable infrastructure for collaborative research and excellence in clinical care, the GLIA-CTN Pilot Project Award is designed to enhance clinical trial readiness in the leukodystrophies through clinical/translational research in biomarkers, or assays to assess therapeutics, or other initiatives directed towards clinical trial readiness.

Eligibility Criteria: Candidates for the award must have a doctoral degree within the health professions (e.g., MD, DO, DDS, DMD, OD, DC, PharmD) and be actively affiliated with a US-based academic and/or health care institution. Individuals with degrees in nursing research and/or practice, who are licensed to practice clinically, may be eligible.

Application Due Date: Applications accepted on a rolling basis.

Term: One Year

Opportunity Type: Education and Career Development

Goal: The GLIA-CTN Career Development Award is a mentored award designed to provide "protected time" for clinically trained individuals to receive supervised training in biomedical research related to leukodystrophies. A long-term goal is to establish a Leukodystrophy Center at each award recipient’s local institution. The award supports a period of supervised research, in conjunction with career development opportunities, for physician-scientists who require additional mentored training and support during development of an innovative research project.

Sponsor: Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

Eligibility Criteria: Candidates for the award must have a doctoral degree within the health professions (e.g., MD, DO, DDS, DMD, OD, DC, PharmD) and be actively affiliated with a US-based academic and/or health care institution. Individuals with degrees in nursing research and/or practice, who are licensed to practice clinically, may be eligible.

Application Due Date: 2026-02-28

Term: One Year